This week in Drug Discovery (17 – 21 November)
News round-up for 17 – 21 November by Bruno Quinney, Content Team at DDW.
This week in DDW, research into bacterial species and diseases gets top billing. Elsewhere, vaccines could offer groundbreaking solutions to cervical and lung cancer.
The top stories:
Medication detrimental to gut microbiome, research finds
The effect of common medication on the gut microbiome could have a detrimental impact on metabolism, the immune system and overall health, a new study reveals.
Read more…
GSK and Fleming Initiative launch programmes to tackle AMR
The six ‘Grand Challenges’ will bring together scientific expertise and the latest technologies, including AI, to find new ways to slow the progress of AMR.
Scientists create nasal vaccine for treating cervical cancer
Researchers at Chiba University in Japan have developed a new nasal therapeutic vaccine as a non-invasive treatment option for cervical cancer.
2026 trial will test LungVax, the first vaccine to prevent lung cancer
A world-first clinical trial is launching to test an experimental vaccine designed to prevent lung cancer in people at high risk of the disease.
UK set to transform nuclear materials into cancer therapies
Nuclear materials recycled in the UK are set to be used to develop cutting-edge cancer treatments.
Read more…
